Robert L. Ferris named executive director of UNC Lineberger—with an additional job as chief of oncology services

Nivolumab demonstrates superiority over standard of care for head-and-neck cancer in phase III trial

The Groupe d’Oncologie Radiothérapie Tête Et Cou, also known as the Head and Neck Oncology and Radiotherapy Group or GORTEC, announced that the randomized phase III CheckMate -9KW/NIVOPOSTOP GORTEC 2018-01 trial evaluating nivolumab (Opdivo) as a post-operative treatment component for resected patients with locally advanced squamous cell carcinoma of head and neck with high risk of relapse met its primary endpoint of disease-free survival across all comers.

January 17, 2025

Vol.51 No.02

In Brief

UNC researchers awarded up to $10M to leverage data science

A team of UNC-Chapel Hill researchers has been awarded up to $10 million in Advanced Research Projects Agency for Health funding to develop the Cancer Identification and Precision Oncology Center (CIPOC).

December 06, 2024

Vol.50 No.45

In Brief

LSU Health New Orleans receives $3.1M grant to study head-and-neck cancer incidence in people living with HIV

LSU Health New Orleans was awarded a five-year, $3.1 million grant from the National Institute of Dental and Craniofacial Research.

November 15, 2024

Vol.50 No.43

Regulatory News

FDA extends shelf-life for IV fluids in shortage after Hurricane Helene

More than a month has passed since Hurricane Helene took out Baxter North Cove plant, which manufactured 1.5 million IV fluid bags per day, supplying 60% of the intravenous solutions nationwide.

November 01, 2024

Vol.50 No.41

By Claire Marie Porter

Clinical

Randomized trial failed to accrue, but data point to preoperative chemo as viable option in sinonasal cancer

If clinical research were anything like fly fishing, the scientific question that EA3163 trial attempted to answer might be considered “the one that got away”.

SU2C announces grants supporting research in six cancer types

Stand Up To Cancer announced grants to several teams of leading cancer investigators in support of cutting-edge research in a variety of cancers including head and neck, pediatric, pancreatic, breast, rectal, and gastro-esophageal cancers, as well as research focused on how the microbiome communicates with the immune system.

October 18, 2024

Vol.50 No.39

Robert L. Ferris named executive director of UNC Lineberger—with an additional job as chief of oncology services

YOU MAY BE INTERESTED IN

Nivolumab demonstrates superiority over standard of care for head-and-neck cancer in phase III trial

UNC researchers awarded up to $10M to leverage data science

LSU Health New Orleans receives $3.1M grant to study head-and-neck cancer incidence in people living with HIV

FDA extends shelf-life for IV fluids in shortage after Hurricane Helene

Randomized trial failed to accrue, but data point to preoperative chemo as viable option in sinonasal cancer

SU2C announces grants supporting research in six cancer types

Renew today!

Subscriber content

Never miss an issue!

Login